Oculis Holding AG (OCS)
Last updated: 2026-10-21 08:58:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Oculis Holding AG (OCS) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $7.48, with a market capitalization of $450.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.02 to $34.48. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$450.82M | |
$7.29 | |
$34.48 | |
$6.26 | |
$7.32 | |
257.01K | |
264.48K | |
-- | |
$34.48 | |
$7.02 | |
-- | |
-- |
Oculis Holding AG (OCS) Pre-Market Stock Price
Oculis Holding AG (OCS) is trading at $7.28 in pre-market trading as of 2026-10-20 23:31:00, down 0.53% ($0.04) from the previous close of $7.32
Pre-market trading shows how investors are pricing OCS before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Oculis Holding AG (OCS) 7-Day Stock Price Change
Over the past seven days, Oculis Holding AG (OCS) moved from $7.88 to $7.48, representing a decline of 5.03% ($0.40).
The stock traded between $7.02 and $8.33 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 368.84 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
OCS 52-Week Price Position
Position in Range: 1.7%
OCS is currently trading at $7.48, placing it 1.7% of the way from its 52-week low of $7.02 to its 52-week high of $34.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Oculis Holding AG (OCS)?
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Oculis Holding AG Information
| Employees | 67 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Oculis Holding AG (OCS) Stock on MEXC
Eligible investors can buy real shares of Oculis Holding AG (OCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Oculis Holding AG (OCS) stock price today?
2.Is OCS stock going up or down today?
3.What is OCS pre-market price?
4.What is OCS after-hours price?
5.Is OCS stock trading now?
6.Where does OCS sit relative to its 52-week high and low?
7.What sector is Oculis Holding AG in?
8.What is Oculis Holding AG's market capitalization and where is it listed?
9.How is OCS valued in terms of P/E ratio and EPS?
10.Does Oculis Holding AG pay a dividend?
Explore More US Stocks
Search Stocks
OCS Stock Calculator
Estimate the value between OCS shares and USD.
OCS Shares to USD
1.00 OCS shares = 7.484 USD
Calculations are estimates based on the latest available price and are for reference only.


